Facilities for Regeneron Canada in thriving Mississauga/GTA biotech hub signal its growth
and readiness to bring more of its life-transforming innovative
medicines for serious diseases to Canadians
MISSISSAUGA, ON, Jan. 21,
2025 /CNW/ - Regeneron Canada Company today
officially opened its first headquarters that will allow it to
better serve the needs of Canadian patients who may benefit from
its life-transforming, innovative medicines for serious
diseases.
The facility is located in the thriving biotechnology hub of
Mississauga, a vital part of the
important and growing sector in the Greater Toronto Area (GTA) and in Ontario as a whole.
Taking part in the official opening ceremonies with leaders from
Regeneron Canada and the Regeneron Global Headquarters in
Tarrytown, NY, were Nina Tangri, Associate Minister of Small
Business and MPP Mississauga – Streetsville, Deepak
Anand, MPP for Mississauga
– Malton, Brett McDermott, Director of Government and
Stakeholder Relations, Mississauga Board of Trade, and
Bradley Harker, Principal Commercial
Officer, U.S. Commercial Service | U.S. Department of Commerce |
International Trade Administration, US Embassy and Consulates in
Canada.
"The opening of this new Canadian office marks an important
milestone in the growth of Regeneron and its ability to help
Canadian patients who are dealing with serious medical challenges,"
said Acher Elfassy, Country Manager
(Immunology).
"We look forward to continuing to build our operations and
advance the next frontier of medicine in Canada from this new base in Mississauga," said Jayne Paterson,
Oncology Country Manager of Regeneron Canada.
"With a highly-skilled workforce and thriving research
environment, Ontario continues to
solidify its position as a global leader in biomanufacturing,
fostering innovation and driving the development of next-generation
health solutions," said Vic Fedeli,
Minister of Economic Development, Job Creation and Trade. "We
congratulate Regeneron on the opening of its new headquarters in
Mississauga and look forward to
supporting their success, as they continue to expand their
footprint across Ontario."
Regeneron is a leading biotechnology company that was founded
and is led by physician-scientists to translate science into
medicines. This has led to the development of numerous approved
treatments and product candidates, most of which were homegrown in
Regeneron laboratories, for cancer and hematologic conditions as
well as eye, cardiovascular, metabolic, inflammatory, neurologic,
infectious and rare diseases.
Launched in 1988, Regeneron has more than 14,000 employees
around the world, with locations in North
America, Europe and
Asia. Regeneron-invented medicines
are available in more than 100 countries and are being studied in
clinical trials in approximately 60 countries, including
Canada.
Regeneron pushes the boundaries of scientific discovery
and accelerates drug development. Regeneron reinvests around
30 percent or more of its revenue into research and development to
build new technologies and advance even more investigational
medicine for patients in need. The company is shaping the next
frontier of medicine and pioneering genetic medicine platforms,
enabling the identification of innovative targets and complementary
approaches to potentially treat or cure diseases.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company
that invents, develops and commercializes life-transforming
medicines for people with serious diseases. Founded and led by
physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to numerous
approved treatments and product candidates in development,
most of which were homegrown in our laboratories. Our medicines and
pipeline are designed to help patients with eye diseases, allergic
and inflammatory diseases, cancer, cardiovascular and metabolic
diseases, neurological diseases, hematologic conditions, infectious
diseases, and rare diseases.
For more information, please visit www.regeneron.ca
or www.Regeneron.com or follow Regeneron on LinkedIn
or Instagram.
SOURCE Regeneron Canada
